General MedicationsINTRAVENOUSGeneric

CYSTEINE HYDROCHLORIDE

Standard Dose

500MG/10ML (50MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CYSTEINE HYDROCHLORIDE is listed in Drugs@FDA under application 214082 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CYSTEINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 500MG/10ML (50MG/ML) Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2023-03-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYSTEINE HYDROCHLORIDE is listed in Drugs@FDA under application 214082 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYSTEINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 500MG/10ML (50MG/ML) Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2023-03-01 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.